Pneumocystis carinii pneumonia: therapy and prophylaxis.

The Journal of infectious diseases ·Vol. 158 ·No. 1 ·1988-07-00 ·Pages 254-9

Kovacs JA, Masur H

Abstract

暂无摘要

MeSH Terms

Acquired Immunodeficiency Syndrome/complications Anti-Bacterial Agents/administration & dosage,therapeutic use Dapsone/administration & dosage,therapeutic use Drug Combinations/administration & dosage,adverse effects,therapeutic use Drug Therapy, Combination Humans Pentamidine/administration & dosage,therapeutic use Pneumonia, Pneumocystis/drug therapy,etiology,prevention & control Pyrimethamine/therapeutic use Quinazolines/therapeutic use Recurrence Sulfadiazine/therapeutic use Sulfamethoxazole/administration & dosage,adverse effects,therapeutic use Trimethoprim/administration & dosage,adverse effects,therapeutic use Trimethoprim, Sulfamethoxazole Drug Combination Trimetrexate

Chemicals

Anti-Bacterial Agents Drug Combinations Quinazolines Sulfadiazine Pentamidine Trimethoprim, Sulfamethoxazole Drug Combination Dapsone Trimethoprim Sulfamethoxazole Trimetrexate Pyrimethamine

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Kovacs J A

Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland 20892.

Masur H

Article Info

Journal

The Journal of infectious diseases

Abbr.

J Infect Dis

ISSN

0022-1899

DOI

10.1093/infdis/158.1.254

Published

1988-07-00

Pages

254-9

Language

English

Region

United States

NLM ID

0413675

Subset

External Links

PubMed source DOI: 10.1093/infdis/158.1.254 View journal details

Analysis Services

Pneumocystis carinii pneumonia: therapy and prophylaxis.

Contact

WeChat Official Account